These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35636927)

  • 21. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
    Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
    Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The versatility of macrophage heterogeneity in liver fibrosis.
    Gao CC; Bai J; Han H; Qin HY
    Front Immunol; 2022; 13():968879. PubMed ID: 35990625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.
    Peiseler M; Schwabe R; Hampe J; Kubes P; Heikenwälder M; Tacke F
    J Hepatol; 2022 Oct; 77(4):1136-1160. PubMed ID: 35750137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Macrophages in Liver Fibrosis.
    Sun C; Matsukawa A
    Acta Med Okayama; 2024 Feb; 78(1):1-8. PubMed ID: 38419308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of hepatic macrophages in liver metastasis.
    Keirsse J; Van Damme H; Geeraerts X; Beschin A; Raes G; Van Ginderachter JA
    Cell Immunol; 2018 Aug; 330():202-215. PubMed ID: 29661474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophages in the Aging Liver and Age-Related Liver Disease.
    Stahl EC; Haschak MJ; Popovic B; Brown BN
    Front Immunol; 2018; 9():2795. PubMed ID: 30555477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophages in necrotic liver lesion repair: opportunities for therapeutical applications.
    Wang Y; Rodrigues RM; Chen C; Feng D; Maccioni L; Gao B
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1556-C1562. PubMed ID: 38618702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context.
    Guillot A; Tacke F
    Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Eye on Kupffer Cells: Development, Phenotype and the Macrophage Niche.
    Elchaninov A; Vishnyakova P; Menyailo E; Sukhikh G; Fatkhudinov T
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver macrophages in tissue homeostasis and disease.
    Krenkel O; Tacke F
    Nat Rev Immunol; 2017 May; 17(5):306-321. PubMed ID: 28317925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of macrophage activation in the liver after acute injury: Role of the fibrinolytic system.
    Roth K; Strickland J; Copple BL
    World J Gastroenterol; 2020 Apr; 26(16):1879-1887. PubMed ID: 32390699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of heterogenous hepatic macrophages in the progression of liver diseases.
    Lee KJ; Kim MY; Han YH
    BMB Rep; 2022 Apr; 55(4):166-174. PubMed ID: 35321784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to Infections During Acute Liver Injury Depends on Transient Disruption of Liver Macrophage Niche.
    Lopes ME; Nakagaki BN; Mattos MS; Campolina-Silva GH; Meira RO; Paixão PHM; Oliveira AG; Faustino LD; Gonçalves R; Menezes GB
    Front Immunol; 2022; 13():892114. PubMed ID: 35967353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages in Zebrafish Models of Liver Diseases.
    Shwartz A; Goessling W; Yin C
    Front Immunol; 2019; 10():2840. PubMed ID: 31867007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial non-alcoholic steatohepatitis leading to hepatocellular carcinoma.
    Neuman MG; Cohen LB; Malnick S
    Chem Biol Interact; 2020 May; 323():109054. PubMed ID: 32217109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer-Challenges and opportunities.
    Kohlhepp MS; Liu H; Tacke F; Guillot A
    Front Mol Biosci; 2023; 10():1129831. PubMed ID: 36845555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models.
    Degroote H; Lefere S; Vandierendonck A; Vanderborght B; Meese T; Van Nieuwerburgh F; Verhelst X; Geerts A; Van Vlierberghe H; Devisscher L
    Oncotarget; 2021 Mar; 12(6):562-577. PubMed ID: 33796224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis.
    Nalkurthi C; Schroder WA; Melino M; Irvine KM; Nyuydzefe M; Chen W; Liu J; Teng MWL; Hill GR; Bertolino P; Blazar BR; Miller GC; Clouston AD; Zanin-Zhorov A; MacDonald KPA
    JHEP Rep; 2022 Jan; 4(1):100386. PubMed ID: 34917911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Hepatic Inflammation via Macrophage Cell Death.
    Li Z; Weinman SA
    Semin Liver Dis; 2018 Nov; 38(4):340-350. PubMed ID: 30357771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.